ENTRY       D08775            Mixture   Drug
NAME        Abacavir sulfate and lamivudine;
            Epzicom (TN)
PRODUCT     EPZICOM (ViiV Healthcare Company)
  GENERIC   ABACAVIR AND LAMIVUDINE (Aurobindo Pharma Limited)
            ABACAVIR AND LAMIVUDINE (Cipla USA)
            ABACAVIR AND LAMIVUDINE (Laurus Labs Limited)
            ABACAVIR AND LAMIVUDINE (Lupin Pharmaceuticals)
            ABACAVIR AND LAMIVUDINE (Zydus Lifesciences Limited)
            ABACAVIR AND LAMIVUDINE (Zydus Pharmaceuticals USA)
COMPONENT   Abacavir sulfate [DR:D00891], Lamivudine [DR:D00353]
CLASS       Antiviral
             DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
             DG03107  Anti-HIV agent
REMARK      Therapeutic category: 6250
            ATC code: J05AR02
            Product: D08775<JP/US>
EFFICACY    Antiviral
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR02 Lamivudine and abacavir
                  D08775  Abacavir sulfate and lamivudine &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Combinations
               Abacavir Sulfate/ Lamivudine
                D08775  Abacavir sulfate and lamivudine
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D08775  Abacavir sulfate and lamivudine
            Drug groups [BR:br08330]
             Antiviral
              DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
               D08775  Abacavir sulfate and lamivudine
              DG03107  Anti-HIV agent
               D08775  Abacavir sulfate and lamivudine
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D08775  Abacavir sulfate and lamivudine
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D08775  Abacavir sulfate and lamivudine &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D08775
DBLINKS     PubChem: 96025458
///
